Literature DB >> 732896

Crude substance P from brain contains a cholecystokinin-like peptide.

G Zetler, D Cannon, D Powell, P Skrabanek, J J Vanderhaeghen.   

Abstract

The subfractions Fa, Fb, and Fc of crude substance P (SP) preparations made from human and bovine brains were analysed for SP and the COOH-terminal octapeptide of cholecystokinin (CCK-8). The methods were specific radioimmunoassays (RIAs) for SP and CCK-8, and bioassays on isolated organs of the guinea pig: the ileum, the gallbladder and the field-stimulated vas deferens. 1. In bioassays of synthetic peptides the vas deferens reacted specifically to SP and the gallbladder to CCK-8. 2. RIAs and bioassays revealed unequivocally that most of SP-like activity was present in Fb, while Fc contained mainly CCK-8-like activity. Varying results were obtained with Fa. 3. The pharmacologically active principle of Fc is CCK-8 or a closely related peptide. Earlier results concerning the pharmacological and neurochemical properties of Fc must be ascribed to this peptide.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 732896     DOI: 10.1007/bf00508292

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  New peptide in the vertebrate CNS reacting with antigastrin antibodies.

Authors:  J J Vanderhaeghen; J C Signeau; W Gepts
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

2.  [Substance P, a polypeptide from the intestine and the brain, with depressive, hyperalgesic and morphine antagonist effects on CNS].

Authors:  G ZETLER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

3.  High-sensitivity radioimmunoassay for substance P.

Authors:  R O'Connell; P Skrabanek; D Cannon; D Powell
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

4.  Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin.

Authors:  P Robberecht; M Deschodt-Lanckman; J J Vanderhaeghen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  [Distribution of gut-centracting peptides in human brain].

Authors:  J Baldauf; H Iven; G Zetler
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

6.  [Active peptides in substance P preparations from cortex, globus pallidus and substantia nigra of human brains].

Authors:  J Baldauf; P Harnacke; G Zetler
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

7.  Pharmacologically active peptides in extracts from cortical and subcortical tissues of human and bovine brain.

Authors:  G Zetler; J E Hümpel; H Iven
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

8.  Mode of action of cholecystokinin and related peptides on gallbladder muscle.

Authors:  W M Yau; G M Makhlouf; L E Edwards; J T Farrar
Journal:  Gastroenterology       Date:  1973-09       Impact factor: 22.682

9.  Immunochemical evidence of cholecystokinin-like peptides in brain.

Authors:  G J Dockray
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

10.  Localisation of gastrins to neuro- and adenohypophysis.

Authors:  J F Rehfeld
Journal:  Nature       Date:  1978-02-23       Impact factor: 49.962

View more
  1 in total

1.  The release of rat intestinal cholecystokinin after oral trypsin inhibitor measured by bio-assay.

Authors:  S J Brand; R G Morgan
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.